Ming Li, PhD

Professor of Research Population and Public Health Sciences

Image of Ming Li, PhD
Is this your profile? Click to edit

Overview

Dr. Ming Li is a Professor in the Division of Biostatistics of the Department of Population and Public Health Sciences starting January 2020.

Dr. Li has extensive experience leading Cores to provide integrated state-of-the-art biostatistics and clinical research informatics support for cancer research spanning basic and translational science to clinical studies, and cancer etiology to cancer control. Dr. Li has served previously as the Director of the Biostatistics and Bioinformatics Core at Case Western Reserve University Comprehensive Cancer Center and now as the Director of the Data Science Core at the USC Norris Comprehensive Cancer Center. With more than 20 years of collaborative research with principal investigators in the cancer field, as primary statistician for numerous grants and projects, Dr. Li has played a key role in multiple aspects, including designing experiments, providing statistical expertise, analyzing data from complex design, supervising staff statisticians, interpreting results, drafting manuscripts, and writing statistical sections for grants.

Education and Training

  • University of Michigan, Ann Arbor, MI — PhD — 11/2002 — Statistics and Management Science
  • University of Michigan, Ann Arbor, MI — MS — 05/1999 — Statistics
  • Nankai University, Tianjin, China — BA — 07/1995 — Mathematical Statistics

Research Keywords

  • Cancer Biostatistics
  • Multi-Omics Data Analysis
  • Translational Bioinformatics
  • AI/Machine Learning

Publications

  • Oral Nicotine Product Use and E-Cigarette Use Persistence in Adolescents and Young Adults: An Analysis Using Augmented Inverse Probability Weighting. Am J Epidemiol. 2026 Feb 21.. View in PubMed
  • Trends in Daily Nicotine Vaping and Unsuccessful Quit Attempts in Youths. JAMA Netw Open. 2025 Nov 03; 8(11):e2541061.. View in PubMed
  • Correlations Between Flavored E-Cigarette Use and Tobacco and Substance Use Among US Youth, 2021 to 2023. Milbank Q. 2025 11; 103(S1):392-410.. View in PubMed
  • Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non-Small Cell Lung Cancer Patients. Cancer Res Commun. 2025 07 01; 5(7):1082-1094.. View in PubMed
  • Reply by Authors. J Urol. 2025 Jan; 213(1):70.. View in PubMed
  • Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors. J Urol. 2025 01; 213(1):60-70.. View in PubMed
  • Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J Clin Oncol. 2023 06 01; 41(16):3009-3018.. View in PubMed
  • Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm. J Med Econ. 2023 Jan-Dec; 26(1):403-410.. View in PubMed
  • Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Ann Surg Oncol. 2023 Feb; 30(2):1017-1025.. View in PubMed
  • Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes. Mol Genet Genomic Med. 2022 10; 10(10):e2031.. View in PubMed